Enzyme Modulators
Enzyme modulators are compounds that can enhance or inhibit the activity of enzymes, thereby regulating the rate of biochemical reactions. These modulators play a critical role in controlling metabolic pathways, cell signaling, and various physiological processes. Enzyme modulators are widely used in research and drug development to study enzyme functions and to develop therapeutic agents. At CymitQuimica, we offer a comprehensive range of high-quality enzyme modulators to support your research in enzyme regulation and drug discovery.
Subcategories of "Enzyme Modulators"
Found 690 products for "Enzyme Modulators". Showing the first 500.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Carbimazole - Bio-X ™
CAS:Carbimazole is an imidazole antithyroid agent that is used to treat hyperthyroidism. It reduces the production of diiodotyrosine and thyroxine, as well as the uptake and concentration of inorganic iodine by the thyroid. Once it has been converted to methimazole, the thyroid peroxidase enzyme is inhibited from coupling and iodinating the tyrosine residues on thyroglobulin therefore lowering the production of the thyroid hormones T3 and T4.
Formula:C7H10N2O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:186.23 g/molS-Rolipram
CAS:Inhibitor of PDE4 enzyme; anti-inflammatoryFormula:C16H21NO3Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:275.34 g/molMilrinone - Bio-X ™
CAS:Milrinone has an application for use in the treatment of heart failure. It has been shown to increase cardiac output and decrease left ventricular end diastolic pressure (LVEDP). Milrinone also increases the amount of oxygen delivered to the tissues by increasing cardiac contractility. Milrinone is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formula:C12H9N3OPurity:(%) Min. 95%Color and Shape:PowderMolecular weight:211.22 g/molPravastatin sodium
CAS:HMG-CoA reductase inhibitor
Formula:C23H35NaO7Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:446.51 g/molCarfilzomib
CAS:Inhibits proteosomes of class peptide epoxyketone; antineoplastic
Formula:C40H57N5O7Purity:Min. 95%Color and Shape:PowderMolecular weight:719.91 g/molAbiraterone - Bio-X ™
CAS:Controlled ProductAbiraterone is an anti-cancer drug that has been shown to be effective in treating prostate cancer. It works by blocking the production of testosterone by inhibiting androgen synthesis. Abiraterone does this by inhibiting CYP17A1, which converts cholesterol into pregnenolone, and then into progesterone and testosterone. Furthermore, it binds to the enzyme steroid 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). Abiraterone is usually a last resort for patients who have stopped responding to other lines of hormone therapies, which is known as second-line therapy.
Formula:C24H31NOPurity:Min. 95%Color and Shape:PowderMolecular weight:349.51 g/molNitazoxanide - Bio-X ™
CAS:Nitazoxanide acts as a noncompetitive inhibitor of the pyruvate: ferredoxin/flavodoxin oxidoreductases of various microorganism with Ki values between 2 and 10 μM. Nitazoxanide is clinically relevant for its broad-spectrum action to reduce the growth of bacteria, various parasites, and especially for its efficacy against the pathogen Helicobacter pylori. Nitazoxanide also has been shown to be effective in treating inflammatory bowel disease and acute enteritis caused by bacteria. In 2021, nitazoxanide was tested for the treatment of COVID-19 patients with mild symptoms due to its broad antiviral action.Formula:C12H9N3O5SPurity:Min. 90 Area-%Color and Shape:PowderMolecular weight:307.28 g/mol4-5-(4-Pyridylmethylamino)pyrazolo1,5-apyrimidin-3-ylbenzamide
CAS:Selective inhibitor of the mutated RET variant RETV804M, which is the anticipated drug-resistant RET mutant that can occur in tumours treated with kinase inhibitors. The compound has a biochemical IC50 of 0.02 µM and selectivity for purified RETV804M over purified RET and KDR of 3.7 and 110, respectively. The efficacy of the compound was shown also in cell cultures with IC50 of 4.4 µM, and cell assay selectivity for RETV804M over RET and KDR of 0.89 and 2.3, respectively.Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:344.37 g/molA 1070722
CAS:High affinity inhibitor of glycogen synthase kinase GSK-3 with Ki of 0.6 nM. A 1070722 showed favourable characteristics for the penetration across blood brain barrier. A 1070722 was also shown to reduce the phosphorylation of microtubule-associated protein Tau.Formula:C17H13F3N4O2Purity:Min. 95%Color and Shape:SolidMolecular weight:362.31 g/molNintedanib ethanesulfonate
CAS:Used for treatment of idiopathic pulmonary fibrosisFormula:C31H33N5O4•C2H6O3SPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:649.76 g/molGSK 1904529A
CAS:Inhibitor of IGF1 receptorFormula:C44H47F2N9O5SPurity:Min. 95%Molecular weight:851.33889Bragsin 2
CAS:Inhibitor of BRAG2-mediated activation of Arf GTP-ase. In vitro experiments showed that Bragsin2 inhibits the Arf GTP-ase activation that is mediated by a nucleotide exchange factor BRAG2 in a membrane-dependent manner. Bragsin2 interacts with the PH domain of BRAG2 protein as well as membrane, which prevents the activation of lipidated Arf. Bragsin2 affects the trans-Golgi network and was shown to affect the tumour sphere in breast cancer cell lines.Formula:C11H6F3NO5Purity:Min. 95%Color and Shape:SolidMolecular weight:289.16 g/molSD 0006
CAS:SD 0006 is a small-molecule inhibitor, which is synthesized through specialized chemical processes. It functions by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a significant role in the inflammatory pathway. This inhibition reduces the production of pro-inflammatory prostaglandins, ultimately leading to a decrease in inflammation.Formula:C20H20ClN5O2Purity:Min. 95%Molecular weight:397.86 g/molEverolimus
CAS:mTOR kinase inhibitor; rapamycin analog; immunosuppressantFormula:C53H83NO14Purity:90%Color and Shape:White Off-White PowderMolecular weight:958.23 g/molPerindopril t-butylamine salt - Bio-X ™
CAS:Perindopril t-butylamine salt inhibits the angiotensin converting enzyme (ACE) to prevent the conversion of angiotensin I to angiotensin II. When used in drug formulations, it has been shown to decrease blood pressure in patients with congestive heart failure. Perindopril also has an effect on the renin-angiotensin system, which regulates blood pressure and fluid homeostasis by promoting vasoconstriction and increasing salt and water retention. Perindopril t-butylamine salt is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formula:C23H43N3O5Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:441.61 g/molGDC 0032
CAS:Inhibitor of PI3K kinase isoforms α, δ, and γFormula:C24H28N8O2Purity:Min. 95%Molecular weight:460.53 g/molOzagrel hydrochloride
CAS:Thromboxane A2 synthetase inhibitor
Formula:C13H12N2O2•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:264.71 g/molPitavastatin calcium
CAS:Inhibitor of HMG-CoA reductase
Formula:C50H46F2N2O8CaPurity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:880.98 g/molNiacinamide
CAS:Vitamin B3; antioxidant; favours cell repairFormula:C6H6N2OPurity:98.5 To 101.5 Area-%Color and Shape:White PowderMolecular weight:122.12 g/molFenoprofen calcium
CAS:Inhibitor of COX-1 and COX-2 cyclooxygenasesFormula:C30H26CaO6Purity:Min. 95%Color and Shape:PowderMolecular weight:524.62 g/mol
